To further explore the potential interaction between SART3 and NOVA2 we utilised NTERA-2 cl.D1 (NT2/D1) cells, a multipotent cell line derived from human embryonic carcinoma cells that express SART3 and NOVA2 and differentiate into various cell types including neurons following appropriate stimulation38. This evidence concerns the gene SART3 and embryonal carcinoma.